NSN 6505-01-103-8583, 6505011038583
Cancelled -> Replaced by 6505012122649

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 011038583
Codification Country: United States
Item Name Code: INC 32823
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Readily Available Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-103-8583

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-103-8583

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-103-8583

National Stock Number (NSN) 6505-01-103-8583, or NIIN 011038583, (diatrizoate meglumine and diatri) was assigned November 21, 1980 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN replaces 1 stock number, 6505012122649.

There are 7 manufacturer part numbers associated with this NSN. 2 of those part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 4 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, 2 suppliers are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

There has been very little demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 02, 2006, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 32823. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505011038583 does not contain precious metals.

This NSN is associated to Schedule B 3006300000: opacifying preparations for x-ray examinations; diagnostic reageants designed to be administered to the patient. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325412: pharmaceutical preparation manufacturing.

This information was last updated on Aug 01, 2025.

Technical Characteristics

III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) DIATRIZOATE MEGLUMINE & DIATRIZOATE SODIUM INJ USP 50ML 25S VI
EXTERIOR CONTAINER QUANTITY: (EXQT) 2
III SUPPLEMENTARY FEATURES: (SUPP) 76% SOLUTION; CONTAINS 4.48 MG SODIUM PER ML; RADIOPAQUE MEDIUM USED IN UROGRAPHY
UNIT OF ISSUE WEIGHT: (SUWT) 8.00 POUNDS
III PROTECTIVE STORAGE FEATURE: (AJCN) SUBJECT TO DAMAGE BY FREEZING
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) DIATRIZOATE MEGLUMINE & DIATRIZOATE SODIUM INJ USP 50ML 25S VI
PHARMACEUTICAL VEHICLE TYPE: (AKJQ) AQUEOUS
MEDICAL DESIGNATION AND GRADE: (MDES) UNITED STATES PHARMACOPEIA
SPECIAL FEATURES: (FEAT) ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: (CRLK) 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: (CQCT) VIAL
PROTECTIVE STORAGE FEATURE: (AJCN) SUBJECT TO DAMAGE BY FREEZING
SUPPLEMENTARY FEATURES: (SUPP) 76% SOLUTION; CONTAINS 4.48 MG SODIUM PER ML; RADIOPAQUE MEDIUM USED IN UROGRAPHY
TOTAL PRIMARY CONTAINER QUANTITY: (CSCW) 25
UNIT PACKAGE TYPE: (PKTY) PACKAGE
EXTERIOR CONTAINER CUBIC MEASURE: (EXME) 0.400 CUBIC FEET
ACTIVE MEDICAMENT MEDICINAL STRENGTH: (AKJA) 66.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT AND 10.000 PERCENTAGE, W/V DIATRIZOATE SODIUM ACTIVE INGREDIENT
UNIT OF ISSUE CUBE: (SUCB) 2.000 CUBIC FEET
EXTERIOR CONTAINER WEIGHT: (ECWT) 16.00 POUNDS